Yurii S. Moroz

Dr. Yurii S. Moroz

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Nature
Verified
Journal Article
Closed access
PDF file
JLJiankun Lyu
Jiankun Lyu
SWSheng Wang
Sheng Wang
TBTrent Balius
Trent Balius
ISIsha Singh
Isha Singh
ALAnat Levit
Anat Levit
JIJohn J. Irwin
John J. Irwin

9 March 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CGChristoph Gorgulla
Christoph Gorgulla
ABAndras Boeszoermenyi
Andras Boeszoermenyi
ZWZi-Fu Wang
Zi-Fu Wang
PFPatrick D. Fischer
Patrick D. Fischer
PCPaul W. Coote
Paul W. Coote
HAHaribabu Arthanari
Haribabu Arthanari

16 March 2014 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
CRCaroline M. Rufo
Caroline M. Rufo
YMYurii S. Moroz
Yurii S. Moroz
OMOlesia V. Moroz
Olesia V. Moroz
JSJan Stöhr
Jan Stöhr
TSTyler A. Smith
Tyler A. Smith
IKIvan Korendovych
Ivan Korendovych
Enzymes fold into unique three-dimensional structures, which underlie their remarkable catalytic properties. The requirement to adopt a stable, folded conformation is likely to contribute to their relatively large size (>10,000 Da). However, much shorter peptides can achieve well-defined conformations through the formation of amyloid fibrils. To test whether short amyloid-forming peptides might in fact be capable of enzyme-like catalysis, we designed a series of seven-residue peptides that act as Zn2+-dependent esterases. Zn2+ helps stabilize the fibril formation, while also acting as a cofactor to catalyse acyl ester hydrolysis. These results indicate that prion-like fibrils are able to not only catalyse their own formation, but they can also catalyse chemical reactions. Thus, they might have served as intermediates in the evolution of modern-day enzymes. These results also have implications for the design of self-assembling nanostructured catalysts including ones containing a variety of biological and non-biological metal ions.

15 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
ASArman A. Sadybekov
Arman A. Sadybekov
ASAnastasiia Sadybekov
Anastasiia Sadybekov
YLYongfeng Liu
Yongfeng Liu
CIChristos Iliopoulos-Tsoutsouvas
Christos Iliopoulos-Tsoutsouvas
XHXi-Ping Huang
Xi-Ping Huang
Vsevolod KatritchVsevolod Katritch
Vsevolod Katritch

10 February 2020 in Nature
Verified
Journal Article
Closed access
PDF file
RSReed M. Stein
Reed M. Stein
HKHye Jin Kang
Hye Jin Kang
JMJohn D. McCorvy
John D. McCorvy
GGGrant C. Glatfelter
Grant C. Glatfelter
AJAnthony J. Jones
Anthony J. Jones
MDMargarita L. Dubocovich
Margarita L. Dubocovich

1 November 2020 in iScience
Verified
Journal Article
Open access
OGOleksandr Grygorenko
Oleksandr Grygorenko
DRDmytro S Radchenko
Dmytro S Radchenko
IDIgor Dziuba
Igor Dziuba
ACAlexander Chuprina
Alexander Chuprina
KGKateryna E. Gubina
Kateryna E. Gubina
YMYurii S. Moroz
Yurii S. Moroz
An approach to the generation of ultra-large chemical libraries of readily accessible (“REAL”) compounds is described. The strategy is based on the use of two- or three-step three-component reaction sequences and available starting materials with pre-validated chemical reactivity. After the preliminary parallel experiments, the methods with at least ∼80% synthesis success rate (such as acylation – deprotection – acylation of monoprotected diamines or amide formation – click reaction with functionalized azides) can be selected and used to generate the target chemical space. It is shown that by using only on the two aforementioned reaction sequences, a nearly 29-billion compound library is easily obtained. According to the predicted physico-chemical descriptor values, the generated chemical space contains large fractions of both drug-like and “beyond rule-of-five” members, whereas the strictest lead-likeness criteria (the so-called Churcher's rules) are met by the lesser part, which still exceeds 22 million.